FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - ValueSet, Realm US

13,139 resources

Type: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 11,158

 

Start Prev Rows 7200 - 7400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7620Antacids (FDD)active2017-01
hl7.fhir.us.breast-radiologyR4ValueSet/rde1559-depthRDE1559 Depthdraft2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3212Signs and Symptoms (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3220Disease Type (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3207Lab Test Result Name (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3216Medication Treatment (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3317Antimicrobial Susceptibility Test Method (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3316Antimicrobial Agent (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8036Antibiotic Dose Units (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7693Antibiotic Received (RIBD)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3120Antibiotic Received (Pertussis)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7619Antibiotics (FDD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7553Specimen Type AST (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7557Susceptibility Test Interpretation (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7704Susceptibility Interpretation (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7701AR Test Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7556Susceptibility Test Method (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7559Susceptibility Test Result Quantitative (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7558Susceptibility Test Result Units (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7555Susceptibility Test Type (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7700AR Agent (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8005Antimicrobials (Anthrax)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.45Endometrial Cancer ICD9active2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/conditions-documenting-substance-misuseConditions documenting substance misuseactive2025-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1045Specimen Riskactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6038Morphology of Neoplasms ICD-9-CMactive2012-01
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-brachytherapy-applicator-type-vsBrachytherapy Applicator Type Value Setactivecgp2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.2.7Nutritional Statusactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.326Arboviral Disease [Other] (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.575Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.576Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.577Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.578Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.579Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.580Arboviral Disease [Other] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.963Arboviral Disease [Other] (Disorders) (SNOMED)active2025-02hl7
hl7.fhir.us.registry-protocolsR4ValueSet/ArterialAccessSiteArterial Access Siteactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.7Common substances for allergy and intolerance documentationactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.8Common substances for allergy and intolerance documentation including refutationsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.39Personal Health Goal Options Groupingactive2025-03hl7
ca.on.dhdr.r4.v4R4ValueSet/drug-service-coverageDrug Service Coverageactivehl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.60Social History Type (SCT)active2025-04hl7
hl7.fhir.us.ndhR4ValueSet/NdhAssociatedServersTypeVSAssociated Servers Type Value Settrial-usepa2025-07hl7
hl7.fhir.us.breast-radiologyR4ValueSet/AsymmetryAbnormalityTypeVSAsymmetry Abnormality Type ValueSetactive2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7140Autopsy Planned (NCHS)active2014-01
fhir.ca-bc.clientR4ValueSet/bc-address-validation-value-setBC Address Validation Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-contact-point-system-value-setBC Contact Point System Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-contact-point-use-value-setBC Contact Point Use Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-expertise-value-setBC Expertise Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-identifier-status-value-setBC Identifier Status Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-language-value-setBC Language Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-merge-status-value-setBC Merge Status Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-name-use-value-setBC Name Use value set.active2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-organization-role-value-setBC Organization Role Code Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-practitioner-role-value-setBC Practitioner Role Code Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-address-validation-status-value-setBC Address Validation Status Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-communication-purpose-value-setBC Communication Purpose Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-end-reason-value-setBC End Reason Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-relationship-type-value-setBC Relationship Type Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-license-status-class-value-setBC License Status Class Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-license-status-reason-value-setBC License Status Reason Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-license-status-value-setBC License Status Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-qualification-value-setBC Practitioner Qualification Value Setactive2025-02hl7
hl7.fhir.us.bserR4ValueSet/TaskBusinessStatusVSTask Business Status VSdraft2025-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3318Bacterial Infection Syndrome (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7686Microorganism (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3405Race Category including Unknownactive2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7204Race Category including Refusedactive2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7205Race Category including Null Flavoractive2013-01
hl7.fhir.us.davinci-drug-formularyR4ValueSet/BenefitCostTypeVSBenefit type of costtrial-usephx2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7903GC beta-lactamase result (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3323Birth Outcome (Rubella)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7223Birth Status (NND)active2020-01
fhir.giisR4ValueSet/BirthplaceVSBirthplacedraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3224Blood or body fluid exposure eventactive2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3225Blood or body fluid exposure frequencyactive2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7707Blood Type (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1067Body Substanceactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3117Body Site (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7826Specimen Source Site (VPD)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.967Body siteactive2019-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3131Lab Result (Pertussis)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3073Botulinum Toxin Type (FDD)active2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1237.18Medication Prescribable Brand Nameactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.16Medication Brand Nameactive2024-06hl7
hl7.fhir.us.breast-radiologyR4ValueSet/BreastAssessmentCategoryVSBreast Assessment Category ValueSetactive2022-12hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1560-breast-body-landmarkRDE1560 Breast body landmarkdraft2022-12hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1557-sideRDE1557 Sidedraft2022-12hl7
hl7.fhir.us.directory-queryR4ValueSet/HealthcareServiceCategoryVSHealthcare Service Category Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/HealthcareServiceCategoryVSHealthcare Service CategoryVStrial-usefm2025-02hl7
hl7.fhir.us.ndhR4ValueSet/HealthcareServiceCategoryVSHealthcare Service Category Value Settrial-usepa2025-07hl7
signal.core.r4R4ValueSet/signal-healthcare-service-categorySignal Healthcare Service Categorydraft1pahl7
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-treatment-assessment-procedureOpioid treatment assessment procedureactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.1Substance Reactant for Intoleranceactive2024-06hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-lymphoma-stage-bulky-modifier-vsLymphoma Stage Bulky Modifier Value Setactivecic2025-02hl7
hl7.fhir.us.vdorR4ValueSet/vdor-bystanders-present-vsVDOR Bystander(s) Presentinformativepher2025-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.8.11Medication Product Formactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.114Hematocrit Lab Testactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.117Potassium Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.119Sodium Lab Testactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.127Platelet Count Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.129White Blood Cells Count Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.134Glucose Lab Testactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.139Bicarbonate Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.152Body Temperatureactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.159Body Weightactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1104.10Medicare FFS Payeractive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1104.12Medicare Advantage Payeractive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2363Creatinine Lab Testactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.151Oxygen Saturation by Pulse Oximetryactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.36All Metastatic Sitesactive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.43Breast Canceractive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.44Breast Canceractive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.15All Metastatic Sitesactive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.35All Metastatic Sitesactive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.39Locoregional Breast Canceractive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.38Locoregional Breast Canceractive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.37Locoregional Breast Canceractive2023-10hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFECMSPOSPCT GFE CMS Place of Service Value Settrial-usefm2025-08hl7
signal.core.r4R4ValueSet/place-of-servicePlace Of Servicedraft1pahl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.229COVID19 Related Disease, Test, or Exposureactive2021-03hl7
hl7.fhir.us.davinci-pctR4ValueSet/USClaimMedicalProductOrServiceCodesClaim Medical Product or Service Value Settrial-usefm2025-08hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFEItemCptHcpcsVSPCT GFE Item CPT - HCPCS Value Settrial-usefm2025-08hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/COVID19VaccineCodeVSCOVID-19 Vaccine Codesdraft2023-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.996History Source (CRA)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacCTACTA Heart and Coronary arteriesactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.22CVX Vaccines Administered Complete Setactive2024-06hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/VaccineCodeVSVaccine Codesdraft2023-08hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/InfluenzaVaccineCodeVSInfluenza Vaccine Codesdraft2023-08hl7
hl7.fhir.us.breast-radiologyR4ValueSet/CalcificationDistributionVSCalcificationDistribution ValueSetactive2022-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1189California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative])active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.16All Metastatic Sitesactive2023-10hl7
fhir.cdc.opioid-cds-r4R4ValueSet/cannabinoid-urine-drug-screening-testsCannabinoid class urine drug screeningactive2023-05hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacCTAResultsCardiac CTA Resultsactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacInstabilityTypeCardiac Instability Typeactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7272Case Notification MMG Version (NND)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7271Case Notification Specification Version (NND)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3138Relationship (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7366Relationship (NND)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3158Case Count Status (TB)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7957Relationship (Hansen)active2020-01
hl7.fhir.us.pcoR4ValueSet/pco-categoriesPerson-Centered Categoriesdraft2pc2025-08hl7
hl7.fhir.us.directory-queryR4ValueSet/OrgAliasTypeVSOrganization Alias Typ Value Seteactive2022-12hl7
hl7.fhir.us.ndhR4ValueSet/OrgAliasTypeVSOrganization Alias Type Value Setetrial-usepa2025-07hl7
hl7.fhir.us.directory-queryR4ValueSet/InsurancePlanTypeVSInsurance Plan Type Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/InsurancePlanTypeVSInsurance Plan TypeVStrial-usefm2025-02hl7
hl7.fhir.us.directory-queryR4ValueSet/OrgTypeVSOrganization Type Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdexR4ValueSet/OrgTypeVSOrganization Type VSinformativefm2025-06hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/OrgTypeVSOrganization Type VStrial-usefm2025-02hl7
hl7.fhir.us.ndhR4ValueSet/OrgTypeVSOrganization Type Value Settrial-usepa2025-07hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTBenefitBalanceCategoryVSPCT benefitBalance.category codestrial-usefm2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.2074.1.1.1Immunization Funding Source Excluding Nullsactive2012-01
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-radiotherapy-category-vsRadiotherapy Category Code Max Value Setactivecgp2025-02hl7
hl7.fhir.us.registry-protocolsR4ValueSet/IntraAndPostEventsCath PCI qualified list of Eventsactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7469Microcephaly Causesactive2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.2074.1.1.4Immunization Refusal Reason Excluding Nullsactive2012-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4502Ceftriaxone all code typesactive2024-05hl7
hl7.fhir.us.vrdrR4ValueSet/vrdr-certifier-types-vsCertifier Types Value Setactivepher2024-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3055ECOTOX Chemicals (EPA)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/ChestPainSymptomAssessmentChest Pain Symptom Assessmentactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.930Chest XRay Resultactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3109Travelers Health Info Sourceactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3075Cholera Risk Factor (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3076Cholera Sequelae (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3077Cholera Signs Symptoms (FDD)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/ChronicLungDiseaseChronic Lung Diseaseactivecic2023-11hl7
fhir.org.nz.ig.baseR4ValueSet/citizenship-statusNZ Citizenship statusactive2025-06hl7
fhir.ops-esaviR4ValueSet/ClasificacionDesenlaceVSCódigo desenlaces tras ESAVIactive2021-03hl7
signal.core.r4R4ValueSet/signal-filerepo-classificationSignal FileRepo Classificationdraft2023-09hl7
signal.core.r4R4ValueSet/questionnaire-dacods-source-of-illicit-drugsQuestionnaire DACODS Source Of Illicit Drugsdraft1pahl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1076Situation with Explicit Contextactive2010-01
hl7.fhir.us.pacio-adiR4ValueSet/ADIPersonalAndLegalRelationshipRoleTypeVSPersonal And Legal Relationship Role Typetrial-use2pe2025-08hl7
hl7.fhir.us.pacio-adiR4ValueSet/ADIInterventionPreferencesOrdinalVSIntervention Preferences - Ordinaltrial-use2pe2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7945Clinical Finding (COVID-19)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7832Clinical Manifestation (TBRD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8008Clinical Manifestations (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7541Clinical Manifestations (Babesiosis)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8007Clinical Manifestations (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7968Clinical Manifestations (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7840Clinical Manifestations (Lyme)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7989Clinical Outcome (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3059Clinical Syndrome (Arbovirus)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7195Clinician Observed Lesions (STD)active2020-01
hl7.fhir.us.breast-radiologyR4ValueSet/rde1558-locationRDE1558 Locationdraft2022-12hl7
fhir.kenyaPSIGR4ValueSet/CodeSystemsVSCode Systems ValueSetdraft2025-07hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFETaskRelationshipPCT GFE Task Relationshiptrial-usefm2025-08hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tumor-size-method-vsTumor Size Method Value Setactive3cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.10.14.1.1.13.13Infant Fetal Complications (HL7)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.10.14.91Birth Defects Diagnostic Confirmation (HL7)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.3NAACCR Diagnostic Confirmationactive2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.15NAACCR Gradeactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.12NAACCR Quality of Survivalactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.4NAACCR TNM Clinical Staged Byactive2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.11NAACCR Cancer Statusactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.13NAACCR Screening Resultactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.10.14.93Birth Defects Laterality at Diagnosis (HL7)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.1NAACCR Laterality at Diagnosisactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.22Laterality (NAACCR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.10NAACCR TNM Clinical Stage Descriptoractive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.21TNM Pathologic Stage Descriptor (NAACCR)active2015-01